Rabeprazole also comes as an oral capsule. It may also be used together with antibiotics (eg, amoxicillin, clarithromycin) to treat ulcers associated with infections caused by the H. Daily treatment with gastric acid-suppressing medication such as rabeprazole over a long period of time (e. Use of rabeprazole for treating gastroesophageal reflux disease (GERD) is not recommended in children younger than 1 year of age for Aciphex ® Sprinkle™ capsule or in children younger than 12 years of age for Aciphex ® delayed-release tablets. Rabeprazole ( Aciphex ) is a proton pump inhibitor (PPI). Aciphex Sprinkle ( rabeprazole sodium delayed-release capsules), for oral use, is a proton-pump inhibitor (PPI) indicated for the treatment of Gastroesophageal Reflux Disease ( GERD) in pediatric patients 1 to 11 years of age.
Contact your doctor immediately if you experience any of the following: C. Hypersensitivity reactions may include. Approval: 1999 RECENT MAJOR CHANGES Warnings and Precautions, Acute Tubulointerstitial Nephritis (5. It works by reducing the amount of acid in the stomach. ** Rabeprazole sodium ( Aciphex Sprinkle) delayed release capsule was approved on March 26,. The stability of rabeprazole sodium is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions HIGHLIGHTS OF PRESCRIBING INFORMATION . In adults for following indications:.
Our Aciphex Sprinkle ( rabeprazole sodium delayed-release capsules), for oral use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.. “ ACIPHEX 20” is imprinted in red on one side of the 4 CONTRAINDICATIONS ACIPHEX is contraindicated in patients with known hypersensitivity to rabeprazole , substituted benzimidazoles, or to any component of the formulation. Use of rabeprazole for treating gastroesophageal reflux disease (GERD) is not recommended in children younger than 1 year of age for Aciphex ® Sprinkle™ capsule or in children younger than 12 years of age for Aciphex ® delayed-release tablets. Cases of cyanocobalamin deficiency occurring with acid-suppression therapy have been reported in the literature RABEPRAZOLE / Aciphex (ra BE pray zole) treats heartburn, stomach ulcers, reflux disease, or other conditions caused by too much stomach acid. ACIPHEX ( rabeprazole sodium ) should not be taken by patients who are allergic to rabeprazole sodium or any of its ingredients. You may report side effects to FDA at 1-800-FDA-1088 See full prescribing information for ACIPHEX DELAYED-RELEASE TABLETS. (from Aciphex Prescribing Information ). Low amount of magnesium in the blood. Important Safety Information . Consult your doctor before breastfeeding.
4%) in the 10 mg dose group and in 35 of the 57 subjects (61. RABEPRAZOLE / Aciphex (ra BE pray zole) treats heartburn, stomach ulcers, reflux disease, or other conditions caused by too much stomach acid. Use Aciphex ( rabeprazole delayed-release tablets) as ordered by your doctor. Important Safety Information . Company: Woodward Pharma Services LLC Hyperacidity, GERD, and ulcers Hyperacidity, GERD, and ulcers:. Patients should disclose any medications, such as Methotrexate or Warfarin, that they are taking before taking ACIPHEX , as ACIPHEX can affect how certain oral medications work in the body See full prescribing information for ACIPHEX DELAYED-RELEASE TABLETS. It may also be used together with antibiotics (eg, amoxicillin, clarithromycin) to treat ulcers associated with infections caused by the H. Severe stomach pain, diarrhea that is watery or bloody; sudden pain or trouble moving your hip, wrist, or back; seizure (convulsions); kidney problems --fever, rash, nausea, loss of appetite.
Appropriate studies have not been performed on the relationship of age to the effects of. It is a substituted benzimidazole known chemically as 2- [ [ [4- (3methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H–benzimidazole sodium salt. The active ingredient in ACIPHEX delayed-release tablets is rabeprazole sodium , which is a proton pump inhibitor. Use of rabeprazole for treating gastroesophageal reflux disease (GERD) is not recommended in children younger than 1 year of age for Aciphex ® Sprinkle™ capsule or in children younger than 12 years of age for Aciphex ® delayed-release tablets. Aciphex ( rabeprazole sodium ) is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease ( GERD ), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori ( H. Call your child’s doctor for medical advice about side effects.
When studied in vitro, rabeprazole is chemically activated at pH 1. CIPHEX ® ( rabeprazole sodium ) delayed-release tablets, for oral use Initial U. It inhibits acid transport in porcine gastric vesicles with a half-life of 90 seconds. See full prescribing information for ACIPHEX DELAYED RELEASE TABLETS. Call your child’s doctor for medical advice about side effects. See 17 for PATIENT COUNSELING INFORMATION M. In gastric parietal cells, rabeprazole is protonated, accumulates, and is transformed to an active sulfenamide. Appropriate studies have not been performed on the relationship of age to the effects of. Aciphex ( Rabeprazole ) Generic Name: Rabeprazole Reviewed: January 4, 2021 Rabeprazole is used short-term to treat symptoms of gastroesophageal reflux disease (GERD) in adults and children who. The active ingredient in ACIPHEX delayed-release tablets is rabeprazole sodium , which is a proton pump inhibitor. ACIPHEX ( rabeprazole sodium ) delayed-release tablets, for oral use Initial U.
5.0 out of 5.0
4.7 out of 5.0
4.5 out of 5.0
4.4 out of 5.0